Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200438889> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4200438889 endingPage "2021" @default.
- W4200438889 startingPage "00333" @default.
- W4200438889 abstract "The IMPACT trial demonstrated superior outcomes following 52 weeks of once-daily single-inhaler treatment with fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) (100/62.5/25 μg) compared with once-daily FF/VI (100/25 μg) or UMEC/VI (62.5/25 μg). This study evaluated the cost-effectiveness of FF/UMEC/VI compared with FF/VI or UMEC/VI for the treatment of chronic obstructive pulmonary disease (COPD) from a UK National Health Service perspective.Patient characteristics and treatment effects from IMPACT were populated into a hybrid decision tree/Markov economic model. Costs (GB£ inflated to 2018 equivalents) and health outcomes were modelled over a lifetime horizon, with a discount rate of 3.5% per annum applied to both. Sensitivity analyses were performed to test the robustness of key assumptions and input parameters.Compared with FF/VI and UMEC/VI, FF/UMEC/VI provided an additional 0.296 and 0.145 life years (LYs) (discounted) and 0.275 and 0.118 quality-adjusted life years (QALYs), at an additional cost of £1129 and £760, respectively. Incremental cost-effectiveness ratios (ICERs) for FF/UMEC/VI were £4104/QALY and £3809/LY gained versus FF/VI and £6418/QALY and £5225/LY gained versus UMEC/VI. At a willingness-to-pay threshold of £20 000/QALY, the probability that FF/UMEC/VI was cost-effective was 96% versus FF/VI and 74% versus UMEC/VI. Results were similar in a subgroup of patients recommended triple therapy in the 2019 National Institute for Health and Care Excellence COPD guideline.FF/UMEC/VI single-inhaler triple therapy improved health outcomes and was a cost-effective option compared with FF/VI or UMEC/VI for patients with symptomatic COPD and a history of exacerbations in the UK at recognised cost-effectiveness threshold levels." @default.
- W4200438889 created "2021-12-31" @default.
- W4200438889 creator A5019669640 @default.
- W4200438889 creator A5026383766 @default.
- W4200438889 creator A5037938098 @default.
- W4200438889 creator A5044410034 @default.
- W4200438889 creator A5058947386 @default.
- W4200438889 creator A5067651492 @default.
- W4200438889 creator A5068375481 @default.
- W4200438889 creator A5077611350 @default.
- W4200438889 date "2021-12-16" @default.
- W4200438889 modified "2023-10-01" @default.
- W4200438889 title "Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial" @default.
- W4200438889 cites W1900057785 @default.
- W4200438889 cites W1991297890 @default.
- W4200438889 cites W1999370028 @default.
- W4200438889 cites W2018267132 @default.
- W4200438889 cites W2142724633 @default.
- W4200438889 cites W2444230658 @default.
- W4200438889 cites W2468772595 @default.
- W4200438889 cites W2513086234 @default.
- W4200438889 cites W2604577460 @default.
- W4200438889 cites W2604743750 @default.
- W4200438889 cites W2752535758 @default.
- W4200438889 cites W2784255361 @default.
- W4200438889 cites W2802221596 @default.
- W4200438889 cites W2955647079 @default.
- W4200438889 cites W2991383511 @default.
- W4200438889 cites W3028481585 @default.
- W4200438889 cites W3041372961 @default.
- W4200438889 cites W3112009581 @default.
- W4200438889 doi "https://doi.org/10.1183/23120541.00333-2021" @default.
- W4200438889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35198630" @default.
- W4200438889 hasPublicationYear "2021" @default.
- W4200438889 type Work @default.
- W4200438889 citedByCount "3" @default.
- W4200438889 countsByYear W42004388892022 @default.
- W4200438889 countsByYear W42004388892023 @default.
- W4200438889 crossrefType "journal-article" @default.
- W4200438889 hasAuthorship W4200438889A5019669640 @default.
- W4200438889 hasAuthorship W4200438889A5026383766 @default.
- W4200438889 hasAuthorship W4200438889A5037938098 @default.
- W4200438889 hasAuthorship W4200438889A5044410034 @default.
- W4200438889 hasAuthorship W4200438889A5058947386 @default.
- W4200438889 hasAuthorship W4200438889A5067651492 @default.
- W4200438889 hasAuthorship W4200438889A5068375481 @default.
- W4200438889 hasAuthorship W4200438889A5077611350 @default.
- W4200438889 hasBestOaLocation W42004388891 @default.
- W4200438889 hasConcept C112930515 @default.
- W4200438889 hasConcept C126322002 @default.
- W4200438889 hasConcept C2776042228 @default.
- W4200438889 hasConcept C2776780178 @default.
- W4200438889 hasConcept C2776804153 @default.
- W4200438889 hasConcept C2779028295 @default.
- W4200438889 hasConcept C2780261241 @default.
- W4200438889 hasConcept C3019080777 @default.
- W4200438889 hasConcept C64332521 @default.
- W4200438889 hasConcept C71924100 @default.
- W4200438889 hasConceptScore W4200438889C112930515 @default.
- W4200438889 hasConceptScore W4200438889C126322002 @default.
- W4200438889 hasConceptScore W4200438889C2776042228 @default.
- W4200438889 hasConceptScore W4200438889C2776780178 @default.
- W4200438889 hasConceptScore W4200438889C2776804153 @default.
- W4200438889 hasConceptScore W4200438889C2779028295 @default.
- W4200438889 hasConceptScore W4200438889C2780261241 @default.
- W4200438889 hasConceptScore W4200438889C3019080777 @default.
- W4200438889 hasConceptScore W4200438889C64332521 @default.
- W4200438889 hasConceptScore W4200438889C71924100 @default.
- W4200438889 hasFunder F4320307773 @default.
- W4200438889 hasIssue "1" @default.
- W4200438889 hasLocation W42004388891 @default.
- W4200438889 hasLocation W42004388892 @default.
- W4200438889 hasLocation W42004388893 @default.
- W4200438889 hasOpenAccess W4200438889 @default.
- W4200438889 hasPrimaryLocation W42004388891 @default.
- W4200438889 hasRelatedWork W1978298330 @default.
- W4200438889 hasRelatedWork W1979098016 @default.
- W4200438889 hasRelatedWork W1991319128 @default.
- W4200438889 hasRelatedWork W1994708653 @default.
- W4200438889 hasRelatedWork W2026793908 @default.
- W4200438889 hasRelatedWork W2461775754 @default.
- W4200438889 hasRelatedWork W2906444991 @default.
- W4200438889 hasRelatedWork W4307377253 @default.
- W4200438889 hasRelatedWork W4386033827 @default.
- W4200438889 hasRelatedWork W2565007391 @default.
- W4200438889 hasVolume "8" @default.
- W4200438889 isParatext "false" @default.
- W4200438889 isRetracted "false" @default.
- W4200438889 workType "article" @default.